Home  »  The many hurdles life sciences startups must overcome to commercialize

The many hurdles life sciences startups must overcome to commercialize

Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations.

As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in Hamilton, Ontario and administrator of SOPHIE life sciences commercialization grants, Muggah likens his job to that of a concierge: connecting high-potential startups to funding, infrastructure, and relevant partners to enable the commercialization of health innovation.

A lot of fantastic innovations find their origins in lab environments, but a working experiment doesn’t easily translate to a commercialized product. Speaking with BetaKit, Muggah shared some common hurdles that life sciences startups face as they move from functioning ideas to marketable products…(Read more here)

We are the place for dreamers, innovators, and world-changing ideas. We create an entrepreneurial culture, launch new startups, and accelerate growth for established tech companies, while attracting the next generation of tech talent and innovative entrepreneurs. We connect people and empower talent in Southwestern Ontario. We engineer, level up, catalyze, discover and accelerate our region’s innovation economy.

This website uses cookies to save your preferences, and track popular pages. Cookies ensure we do not require visitors to register, login, or share any identity information.